7^th Union Europe Conference on Lung Health, 22-24 June 2016, Bratislava (Slovakia): a delegate report

Affiliations

¹ Department of Critical Care Medicine, Belarusian State Medical University, Minsk, Belarus;; Clinical Department, Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.

Editorial

Aliaksandr Skrahin. Quant Imaging Med Surg. 2016 Aug.

. 2016 Aug;6(4):338-341.

doi: 10.21037/qims.2016.08.03.

¹ Department of Critical Care Medicine, Belarusian State Medical University, Minsk, Belarus;; Clinical Department, Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.

No abstract available

Conflict of interest statement

The author has no conflicts of interest to declare.

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86. 10.1001/jama.282.7.677 - DOI - PubMed
1. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-8. - PubMed
1. Field SK. Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment? Ther Adv Chronic Dis 2015;6:170-84. 10.1177/2040622315582325 - DOI - PMC - PubMed
1. Blair HA, Scott LJ. Delamanid: a review of its use in patients with multidrug-resistant tuberculosis. Drugs 2015;75:91-100. 10.1007/s40265-014-0331-4 - DOI - PubMed
1. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis. Interim policy guidance.WHO/HTM/TB/2013.6. Available online: http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf?ua=1 - PubMed